Mentax
Mentax Price range: $ 48,00 through $ 185,00
Back to products
Mestinon
Mestinon Price range: $ 64,00 through $ 403,00

Mesterolone

Price range: $ 78,00 through $ 256,00

Mesterolone is a potent oral androgenic medication designed to address conditions caused by a lack of natural testosterone production in men. It is primarily used to treat male hypogonadism, helping to restore hormonal balance and alleviate symptoms of androgen deficiency. The medication effectively improves physical vigor, mental alertness, and general well-being in patients experiencing age-related hormonal decline. In addition to hormone replacement, Mesterolone is utilized to support male fertility by improving sperm count and quality in specific clinical cases. This therapy helps maintain secondary male sexual characteristics while ensuring a steady level of androgenic activity within the body.

Active substance: Mesterolone
SKU: Mesterolone Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Mesterolone: Patient and Clinical Overview

Mesterolone belongs to a class of synthetic androgen derivatives and is chemically categorized as a 1-methylated derivative of dihydrotestosterone (DHT). The drug is formulated for oral administration to address clinical manifestations associated with endogenous androgen deficiency in adult males. In the United States, mesterolone is classified as a Schedule III controlled substance under federal law and is not an FDA-approved drug product for domestic prescription marketing.

Because mesterolone lacks FDA approval for prescription distribution in the United States, any clinical or therapeutic handling must be dispensed in accordance with applicable federal and state regulations governing controlled anabolic-androgenic agents. Patients and healthcare providers must carefully examine the pharmacokinetic properties, security warnings, and potential physiological risks prior to considering therapy involving synthetic androgenic steroids.

Basic Information Overview

Drug Name Mesterolone
Active Ingredient Mesterolone (1 alpha-methyl-17 beta-hydroxy-5 alpha-androstan-3-one)
Therapeutic Class Androgen; Anabolic Steroid Derivative
Dosage Form Oral tablet
Route of Administration Oral
Prescription & Regulatory Status Dispensed in accordance with applicable federal and state regulations; Schedule III controlled substance (unapproved in US)

Pharmacological Profile and Clinical Considerations

Mechanism of Action

The mechanism of action of mesterolone relies on its structural identity as a dihydrotestosterone derivative featuring a methyl substitution at the C1-alpha position. This specific chemical modification enables oral bioavailability by protecting the molecule from rapid hepatic degradation without requiring 17-alpha alkylation. Mesterolone binds directly to androgen receptors in targeted peripheral tissues, thereby influencing protein transcription and male secondary sexual characteristics. Additionally, the drug exhibits high affinity for Sex Hormone-Binding Globulin (SHBG). By binding strongly to SHBG, mesterolone can displace unbound endogenous testosterone, theoretically elevating free testosterone ratios in circulating plasma. Unlike testosterone, mesterolone cannot be converted into estrogenic metabolites via the aromatase enzyme system, preventing aromatization-induced gynecomastia.

Primary Uses and Indications

In international medical jurisdictions where approved, mesterolone is primarily indicated for the treatment of male androgen deficiency, hypogonadism, and related conditions characterized by reduced physical performance or impaired spermatogenesis. It has also been evaluated clinically for male infertility secondary to subnormal androgen levels. In the United States, mesterolone is not an FDA-approved therapeutic agent, meaning any domestic application for androgen replacement therapy or athletic performance enhancement is classified as off-label or unapproved. Non-medical usage for physique enhancement, body composition alteration, or athletic performance is explicitly off-label, unauthorized by regulatory authorities, and associated with adverse systemic health risks.

Dosing and Administration

Clinical dosing of mesterolone in regions where it holds regulatory authorization typically ranges from 25 mg to 75 mg daily, divided into two or three individual doses. The exact regimen depends on the individual therapeutic objective, baseline serum androgen levels, and clinical response. Tablets are taken orally with water, with or without food. Because mesterolone is not an FDA-approved drug product in the United States, formal standardized US prescribing guidelines do not exist. Individual dosage decisions in international protocols require periodic monitoring by a qualified physician to adjust dosage based on therapeutic goals and to mitigate adverse cardiovascular, hepatic, or hormonal effects.

Pharmacokinetics and Metabolism

Following oral administration, mesterolone is absorbed rapidly from the gastrointestinal tract. Peak plasma concentration is generally reached within 1.6 to 3 hours after ingestion. Due to the presence of the 1-alpha-methyl group, the compound resists primary hepatic inactivation while avoiding the liver toxicity often associated with C17-alpha alkylated oral anabolic steroids. Mesterolone is extensively bound to plasma proteins, particularly SHBG and serum albumin. The drug undergoes hepatic biotransformation into inactive metabolites, such as androsterone and epiandrosterone, which are subsequently conjugated with glucuronic acid and eliminated primarily through renal excretion in the urine. The elimination half-life of mesterolone is estimated at approximately 12 to 13 hours.

Drug Interactions

Mesterolone presents several clinically relevant interactions with concomitant medications. Administration of synthetic androgens alongside oral anticoagulants, such as warfarin or coumarin derivatives, may enhance anticoagulant responsiveness and increase the risk of bleeding. Blood glucose levels may also be altered; patients taking antidiabetic agents or insulin may experience potentiated hypoglycemic effects, necessitating dosage adjustments of antidiabetic drugs. Concomitant use with corticosteroids or adrenocorticotropic hormone (ACTH) can exacerbate fluid retention and heighten the risk of peripheral edema, particularly in individuals with pre-existing cardiac, renal, or hepatic compromise. Co-administration with other hepatotoxic or hormonal substances should be strictly managed by a healthcare practitioner.

Adverse Reactions and Warnings

Adverse Reactions and Side Effects

Adverse events linked to mesterolone therapy relate predominantly to its androgenic activity and systemic physiological impact. Common androgenic side effects include acne vulgaris, oily skin, increased facial or body hair growth, and male pattern alopecia in genetically susceptible individuals. Prostatic enlargement (benign prostatic hyperplasia) and urinary hesitance may also occur, particularly in older adult males. Cardiovascular side effects involve alterations in serum lipid profiles, characterized by decreased high-density lipoprotein (HDL) cholesterol and increased low-density lipoprotein (LDL) cholesterol, which may elevate long-term cardiovascular disease risk. Although mesterolone is non-17-alpha-alkylated and generally displays lower hepatic toxicity than alkylated steroids, transient liver enzyme elevations remain possible. High doses or prolonged administration may also suppress endogenous pituitary gonadotropin secretion.

Important Precautions

Prior to initiating mesterolone therapy, comprehensive diagnostic screening is required to exclude underlying conditions that contraindicate androgen administration. The medication is strictly contraindicated in patients with diagnosed or suspected prostate carcinoma or male breast cancer. Careful evaluation is necessary for patients with pre-existing cardiovascular disorders, hypertension, severe hepatic dysfunction, or renal impairment. Serial monitoring of liver function tests, serum lipid panels, complete blood counts (hemoglobin and hematocrit), and prostate-specific antigen (PSA) levels should be performed regularly during androgen therapy. Mesterolone is strictly contraindicated during pregnancy and breastfeeding, as androgenic compounds cause virilization and structural harm to a developing fetus.

Food and Alcohol Considerations

Mesterolone may be taken with or without food; dietary intake does not significantly impair oral absorption. However, co-ingesting tablets with meals may help reduce mild gastrointestinal discomfort if stomach upset occurs. Concurrent consumption of ethanol or chronic alcohol intake should be minimized or avoided entirely. Alcohol consumption can exacerbate hepatic stress, negatively alter lipid metabolism, and impair endogenous hormonal balance, thereby counteracting therapeutic objectives and escalating cardiovascular or liver risks.

When to Seek Immediate Medical Attention

Patients taking mesterolone must be vigilant for severe adverse reactions requiring urgent emergency evaluation. Immediate medical care should be sought if signs of severe allergic reaction develop, such as facial, lip, or tongue swelling, difficulty swallowing, or acute dyspnea. Urgent medical assistance is also warranted if symptoms indicative of cardiovascular distress occur, including severe chest pain, shortness of breath, or sudden severe headache. Persistent abdominal pain, unexplained jaundice (yellowing of the skin or eyes), dark urine, or severe psychological disturbances–such as acute aggression or extreme mood swings–mandate immediate clinical consultation.

Missed Dose Instructions

If a dose of mesterolone is missed, it should be taken as soon as remembered, provided the next scheduled dose is not imminent. If the time is close to the next scheduled administration, the missed dose should be skipped, and the regular dosing schedule resumed. Double doses must never be ingested to make up for a missed tablet, as acute doubling of androgenic compounds increases the likelihood of side effects and hormonal destabilization.

Storage and Expiration

Mesterolone tablets should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), away from excessive heat, moisture, and direct light exposure. Do not store the medication in humid environments such as bathrooms. Keep the tablets in their original packaging and securely out of reach of children and pets. Expired or unused medication must be disposed of properly through local drug take-back programs or state-approved disposal protocols, rather than being flushed down toilets or poured into household drains.

Frequently Asked Questions

What is the primary difference between mesterolone and injectable testosterone replacement therapy?

Mesterolone is an oral dihydrotestosterone (DHT) derivative that does not aromatize into estrogen, whereas injectable testosterone compounds undergo aromatization into estradiol. Additionally, mesterolone exhibits high binding affinity for SHBG, which may alter free testosterone distribution, but it exhibits relatively weak anabolic potency compared to testosterone esters.

Can mesterolone cause estrogen-related side effects like gynecomastia?

No, mesterolone does not convert into estrogen via the aromatase enzyme because it is a 5-alpha reduced DHT derivative. Consequently, it does not directly cause estrogenic side effects such as gynecomastia or fluid retention secondary to estrogen elevation. However, systemic androgenic side effects remain possible.

Is mesterolone approved by the FDA for medical use in the United States?

No, mesterolone is not an FDA-approved pharmaceutical product for medical marketing in the United States. In the US, anabolic-androgenic steroids are regulated as Schedule III controlled substances under federal law, requiring strict regulatory compliance for any lawful handling.

How does mesterolone affect liver enzyme values?

Unlike 17-alpha-alkylated oral anabolic steroids, mesterolone possesses a 1-alpha-methyl group, which significantly reduces hepatic strain. Nevertheless, prolonged use or excessive dosages can still cause mild liver stress or transient alterations in liver enzyme levels, necessitating periodic hepatic monitoring.

Does mesterolone suppress natural testosterone production?

At low to moderate therapeutic doses (e.g., 25 mg to 50 mg daily), mesterolone exerts relatively mild suppression on pituitary gonadotropins (LH and FSH) compared to other anabolic steroids. However, higher dosages or extended administration periods can lead to suppression of endogenous testosterone synthesis.

What should patients monitor while receiving androgen therapy?

Patients undergoing androgen therapy should routinely monitor serum lipid panels (HDL and LDL cholesterol), liver function enzymes, blood pressure, hematocrit/hemoglobin levels, and prostate-specific antigen (PSA) values under the supervision of a licensed physician.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

20 mg

Package

30 tabs

,

60 tabs

,

90 tabs

,

120 tabs

Ενεργός Ουσία